Life Time Posts Strong Q1 2026 Results; DeepValue Report Flags Crowded, Growth-Premium Valuation

What happened

Life Time Group reported double-digit revenue and adjusted EBITDA growth for Q1 2026, citing stronger dues revenue, higher in-center spending, and continued demand for new clubs. Despite the upbeat earnings call, DeepValue's latest master report maintains a 'WAIT' rating with an attractive entry of $22, arguing that the stock already prices in sustained low-teens growth and margin expansion. The report emphasizes that while fundamentals are strong near term, growth is increasingly driven by average revenue per member rather than membership volume, and fixed costs are rising through expanding lease obligations. It also notes that the story has become crowded, with multiple outlets highlighting breakouts and strong momentum, leaving limited margin of safety at the current ~$28 price. The base-case implied value is $30, but with upside to $38 in a bull scenario if comps stay ≥10% and leverage remains controlled—though a bear case sees downside to $20 if consumer spending softens.

Implication

Investors should view the Q1 results as confirmation that execution remains on track, but the report's key takeaway is that the risk/reward is balanced rather than asymmetric. The stock trades at ~22x P/E and ~16x EV/EBITDA, pricing in continued double-digit growth. Any slowdown in ARPU expansion, a consumer downturn that crimps in-center spending, or a need for equity dilution to fund growth could compress multiples. The 'WAIT' rating recommends trimming above $34 and re-entering near $22, where the margin of safety widens. Thus, current holders should consider reducing exposure toward the trim level, while new capital should wait for a better entry point to achieve a 6-18 month return with adequate upside.

Thesis delta

The earnings call reinforces that near-term momentum is intact, but it does not change the fundamental concern that growth is ARPU-led and the model is lease-heavy. The crowded bullish narrative has increased, not decreased, execution risk. The call to wait persists; nothing in the Q1 data contradicts the view that the stock is fairly priced at best.